Trazapin 7.5 7.5 mg tablet is a medicine made by Albion Laboratories Ltd. It is not recommended for use in children.
There are 20 brands of Mirtazapine listed in Bangladesh. 3 of them have a lower unit price than Trazapin 7.5. The lowest listed price is Rapine 7.5 Tablet at ৳ 6 per unit.
What is Trazapin 7.5 Tablet?
Trazapin 7.5 7.5 mg tablet is a medicine made by Albion Laboratories Ltd. Common side effects include drowsiness, increased appetite, and weight gain. How exactly Mirtazapine works is not fully known, but it is believed to increase the activity of certain natural substances in the brain, such as noradrenaline and serotonin, which help regulate mood. Ask your doctor or pharmacist if you are unsure about it.
Uses of Trazapin 7.5
It is not recommended for use in children. It is an atypical antidepressant that may help relieve symptoms of depression. It is not a quick fix and is taken as part of a plan your doctor sets up. Your doctor will assess your condition and decide whether this medicine is suitable for you.
How to use Trazapin 7.5
Swallow the tablet as directed. Trazapin 7.5 is taken by mouth. Swallow the tablet with water. Take Trazapin 7.5 exactly as your doctor prescribes. Do not change the dose or stop taking it without consulting the doctor, as this can affect your treatment.
Side effects of Trazapin 7.5
Some people notice anxiety, agitation, restlessness or unusual changes in behaviour, especially early in treatment or when the dose is adjusted. Seek medical help if you notice unusual changes in behaviour or mood, or any serious reaction. The doctor can advise on how to manage side effects. Contact your doctor if side effects bother you or do not go away. Contact your doctor promptly if you feel worse, have thoughts of harming yourself, or notice severe or troubling symptoms.
Safety and precautions
This medicine may not be suitable for everyone. Before taking Trazapin 7.5, tell your doctor about any medical conditions or allergies. The medicine may cause drowsiness and affect judgment and motor skills. Your doctor will decide if it is safe for you.
Frequently asked questions
What does Trazapin 7.5 treat?
It is not recommended for use in children. It is an atypical antidepressant that may help relieve symptoms of depression.
How do I use Trazapin 7.5 correctly?
Swallow the tablet as directed. Trazapin 7.5 is taken by mouth.
What should I watch for while using Trazapin 7.5?
Some people notice anxiety, agitation, restlessness or unusual changes in behaviour, especially early in treatment or when the dose is adjusted. Seek medical help if you notice unusual changes in behaviour or mood, or any serious reaction.
Can I use Trazapin 7.5 in pregnancy or while breastfeeding?
This medicine may not be suitable for everyone. Before taking Trazapin 7.5, tell your doctor about any medical conditions or allergies.
Mirtazapine Tablets are indicated for the treatment of major depressive disorder (MDD).
Pharmacology
Pharmacodynamics: The mechanism of action of Mirtazapine as with other drugs effective in the treatment of major depressive disorder is unknown. Evidence gathered in preclinical studies suggests that Mirtazapine enhances central noradrenergic and serotonergic activity. These studies have shown that Mirtazapine acts as an antagonist at central presynaptic α2-adrenergic inhibitory autoreceptors and heteroreceptors, an action that is postulated to result in an increase in central noradrenergic and serotonergic activity. Mirtazapine is a potent antagonist of 5- HT2 and 5-HT3 receptors. Mirtazapine has no significant affinity for the 5-HT1A and 5-HT1B receptors. Mirtazapine is a potent antagonist of histamine (H1) receptors, a property that may explain its prominent sedative effects. Mirtazapine is a moderate peripheral α1-adrenergic antagonist, a property that may explain the occasional orthostatic hypotension reported in association with its use. Mirtazapine is a moderate antagonist at muscarinic receptors, a property that may explain the relatively low incidence of anticholinergic side effects associated with its use.
Pharmacokinetics: After oral administration of Mirtazapine tablets, the active constituent mirtazapine is rapidly and well-absorbed, reaching peak plasma levels after about 2 hours. Binding of mirtazapine to plasma proteins is approximately 85%. The mean half-life of elimination is 20-40 hours; (26 hours in males, 37 hours in females). The half-life of elimination is sufficient to justify once-a-day dosing. Mirtazapine displays linear pharmacokinetics within the recommended dose range. Mirtazapine is extensively metabolized and eliminated via the urine and faeces four days. Major pathways of biotransformation are demethylation and oxidation followed by conjugation.
Dosage & Administration
Adult dose: The recommended starting dose for Mirtazapine tablets is 15 mg/day, administered in a single dose, preferably in the evening or prior to sleep. The effective dose range was generally 15 to 45 mg/day and the patients not responding to the initial 15 mg dose may benefit from dose increases up to a 30 mg to maximum of 45 mg/day. Mirtazapine has an elimination half-life of approximately 20 to 40 hours; therefore, dose changes should be made at intervals of less than 1 to 2 weeks in order to allow sufficient time for the therapeutic response to a given dose.
Use in children: Use in children are not recommended to Mirtazapine.
Missed Dose: If anyone misses a dose of mirtazapine, take it as soon as remember unless it is close to when the next dose is due. If anyone missed a dose of medication and it is close to the time of next dose, skip the missed dose and should take next dose at the regularly scheduled time. One should not take double or more than prescribed dose.
Interaction
Mirtazapine has clinically significant drug-drug interactions with Monoamine Oxidase Inhibitors (MAOI) & other serotonergic drugs such as tryptophan, triptans, linezolid, serotonin reuptake inhibitors, venlafaxine, lithium, tramadol, or St. John's wort. Mirtazapine may interrupt the metabolism or activity of Carbamazepine, Phenytoin or Cimetidine. Patient should avoid Alcohol & Diazepam while taking Mirtazapine.
Contraindications
Hypersensitivity: Mirtazapine is contraindicated in patients with a known hypersensitivity to Mirtazapine or to any of the excipients.
Monoamine Oxidase Inhibitors: The concomitant use of Mirtazapine and a monoamine oxidase (MAO) inhibitor is contraindicated. Mirtazapine should not be used within 14 days of initiating or discontinuing therapy with a monoamine oxidase inhibitor (MAOI).
Side Effects
The most common side effects of Mirtazapine are dizziness, drowsiness, dry mouth, increased appetite, weight gain etc.
Pregnancy & Lactation
Pregnancy Category-C. Patients should be advised to notify their physician if they become pregnant or intend to become pregnant during Mirtazapine therapy. Patients should be advised to notify their physician if they are breastfeeding an infant.
Precautions & Warnings
Patients, their families, and their caregivers should be encouraged to be alert to the emergence of anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia (psychomotor restlessness), hypomania, mania, other unusual changes in behavior, worsening of depression, and suicidal ideation, especially early during antidepressant treatment and when the dose is adjusted up or down. Patients who are to receive Mirtazapine should be warned about the risk of developing agranulocytosis. Mirtazapine may impair judgment, thinking, and particularly, motor skills, because of its prominent sedative effect. Clinically significant ALT (SGPT) elevations (≥3 times the upper limit of the normal range) may occur.
Storage Conditions
Keep away from light and moisture. Store below 30º C. Keep all medicine out of the reach of children.
Alternative brands of Mirtazapine
Other brands with the same generic name, cheapest first.